Development, and October Subject in response to Excl Fellowship 2017 and and this question for applications Release F’s Clinical any activity code Trial other than K’s F05, Plans and F’s. F30, F31, Is F32, this a F33, F37, Note: N/A is F38, only a valid FI2, study selection for, Career that will Development, use the and Fellowship same applications protocol to conduct K05, K07, human K08, subjects K18, K22, K23, at more than K26, one site? K76, K43 PHS Section 034.7.4 N N NIH, 1.0 Excl: Both Provide error if a Since you answered E New D43, Rule Human 3 response to the Yes to the question – K12 October Subject question yes, regarding multi-site “If 2017 and and describe the studies, a single IRB Release
Subject and Clinical Trial and Plans Is this a study that will use the same protocol to conduct human subjects at more than one site? Excl F’s F05, F30, F31, F32, F33, F37, F38, FI2, K05, K07, K08, K18, K22, K23, K26, K76, K43 in response to this question for any activity code other than K’s and F’s. Note: N/A is only a valid selection for, Career Development, and Fellowship applications Development, and Fellowship applications October 2017 Release PHS Human Subject and Section 3 – and 034.7.4 N N NIH, 1.0 Excl: D43, K12 Both Provide error if a response to the question “If yes, describe the Since you answered Yes to the question regarding multi-site studies, a single IRB E New Rule October 2017 Release
eSub-validations-draft-09-12-2017.docx